Viewing Study NCT04550637



Ignite Creation Date: 2024-05-06 @ 3:13 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04550637
Status: RECRUITING
Last Update Posted: 2022-10-18
First Post: 2020-05-17

Brief Title: A Multi-center Study of ApixabanAPPROACH
Sponsor: Shanghai Zhongshan Hospital
Organization: Shanghai Zhongshan Hospital

Study Overview

Official Title: A Multi-center Observative Study of Apixaban After Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation
Status: RECRUITING
Status Verified Date: 2022-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of the study is to enroll approximately 200 cases from 10 research centers nationwide completed left atrial appendage occlusion LAAO successfully and give apixaban 5 mg bid postoperatively
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None